Elizabeth A Reilly, DPM
Podiatry · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
11 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Reilly’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G5119 · Deceased
Licence status: Deceased · since 1959 · Mcgill University Faculty of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$74,581
Medicare paid this office $74,581 for 548 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 337 | $33,061 | $55 |
| New patient visit (45+ min) | 98 | $10,101 | $103 |
| New patient visit (30+ min) | 115 | $7,742 | $67 |
| Return visit (30+ min) | 88 | $7,326 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 77 | $3,281 | $18 |
See all 8 services
| Short return visit (20+ min) | 337 | $33,061 | $55 |
| New patient visit (45+ min) | 98 | $10,101 | $103 |
| New patient visit (30+ min) | 115 | $7,742 | $67 |
| Return visit (30+ min) | 88 | $7,326 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 77 | $3,281 | $18 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $800 | $17 |
| Removal of noncancer thickened skin growth, 1 growth | 36 | $747 | $13 |
| Injection into tendon or ligament | 15 | $577 | $34 |
Procedures Medicare counted
| Removal of nail tissue | 139 | More than 72% of doctors who do this |
| Removal of tissue | 17 | More than 67% of doctors who do this |
| Removal or shaving of skin growth | 100 | More than 85% of doctors who do this |
Who their Medicare patients are
548 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 10% · Women 65% · Also on Medicaid 26% · Health risk score 1.40. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 65% · Diabetes 29% · Coronary heart disease 23% · Chronic kidney disease 22% · Cancer 18% · Depression 18% · Heart failure 15% · Atrial fibrillation 14% · COPD 9% · Stroke 7% · Dementia 6%.
The office billed $234,621, Medicare allowed $101,726 and paid $74,581; for 1,334 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 548 | 1,334 | 73 | 1.40 | $234,621 | $74,581 |
| 2023 | 505 | 1,303 | 73 | 1.40 | $258,735 | $78,568 |
| 2022 | 416 | 1,084 | 73 | 1.42 | $176,271 | $60,128 |
| 2021 | 356 | 894 | 74 | 1.54 | $147,572 | $48,545 |
| 2020 | 360 | 1,210 | 72 | 1.72 | $185,659 | $53,845 |
| 2019 | 480 | 1,413 | 72 | 1.63 | $180,210 | $62,032 |
| 2018 | 397 | 1,052 | 71 | 1.83 | $138,234 | $46,001 |
| 2017 | 383 | 744 | 71 | 1.61 | $119,536 | $36,194 |
| 2016 | 270 | 502 | 70 | 1.40 | $96,062 | $26,083 |
| 2015 | 50 | 70 | 71 | 1.25 | $15,195 | $4,115 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Short return visit (20+ min) | 268 | $28,803 | $56 |
| New patient visit (45+ min) | 161 | $16,927 | $105 |
| Return visit (30+ min) | 87 | $7,955 | $82 |
| New patient visit (30+ min) | 102 | $7,048 | $69 |
| Removal of fingernails or toenails, 6 or more nails | 91 | $3,814 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 33 | $703 | $13 |
| Simple separation of fingernail or toenail from nail bed, first nail | 13 | $631 | $49 |
| Removal of noncancer thickened skin growth, 2-4 growths | 22 | $548 | $18 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $163 | $13 |
2022: 8 services
| Short return visit (20+ min) | 218 | $23,601 | $55 |
| New patient visit (45+ min) | 96 | $10,053 | $105 |
| New patient visit (30+ min) | 140 | $8,939 | $64 |
| Return visit (30+ min) | 70 | $6,559 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 71 | $2,719 | $18 |
| Removal of noncancer thickened skin growth, 1 growth | 34 | $749 | $13 |
| Simple separation of fingernail or toenail from nail bed, first nail | 13 | $627 | $45 |
| Removal of noncancer thickened skin growth, 2-4 growths | 18 | $389 | $17 |
2021: 8 services
| Short return visit (20+ min) | 207 | $19,752 | $53 |
| New patient visit (45+ min) | 90 | $9,298 | $103 |
| Return visit (30+ min) | 53 | $5,515 | $84 |
| New patient visit (30+ min) | 72 | $5,275 | $73 |
| Removal of fingernails or toenails, 6 or more nails | 86 | $2,683 | $19 |
| Simple separation of fingernail or toenail from nail bed, first nail | 12 | $627 | $45 |
| Removal of noncancer thickened skin growth, 1 growth | 24 | $474 | $13 |
| Removal of noncancer thickened skin growth, 2-4 growths | 21 | $436 | $17 |
2020: 11 services
| Short return visit (20+ min) | 220 | $20,572 | $43 |
| Return visit (30+ min) | 75 | $6,780 | $70 |
| New patient visit (30+ min) | 93 | $5,661 | $61 |
| New patient visit (45+ min) | 54 | $5,370 | $99 |
| Removal of fingernails or toenails, 6 or more nails | 89 | $3,665 | $20 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $1,023 | $19 |
| Aspiration and/or injection of fluid from medium joint | 17 | $809 | $39 |
| Simple separation of fingernail or toenail from nail bed, first nail | 13 | $684 | $46 |
| Removal of noncancer thickened skin growth, 1 growth | 39 | $674 | $12 |
| Injection into tendon or ligament | 18 | $577 | $30 |
| Aspiration and/or injection of fluid from small joint | 13 | $398 | $27 |
2019: 10 services
| Short return visit (20+ min) | 274 | $24,707 | $43 |
| New patient visit (30+ min) | 145 | $8,800 | $61 |
| Return visit (30+ min) | 116 | $8,545 | $67 |
| Removal of fingernails or toenails, 6 or more nails | 88 | $4,260 | $20 |
| New patient visit (45+ min) | 30 | $3,367 | $112 |
| Simple separation of fingernail or toenail from nail bed, first nail | 19 | $1,160 | $50 |
| Aspiration and/or injection of fluid from small joint | 22 | $978 | $36 |
| Removal of noncancer thickened skin growth, 2-4 growths | 34 | $935 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 34 | $672 | $14 |
| Injection into tendon or ligament | 16 | $669 | $39 |
2018: 9 services
| Short return visit (20+ min) | 242 | $20,628 | $43 |
| New patient visit (30+ min) | 150 | $9,121 | $61 |
| Return visit (30+ min) | 79 | $5,221 | $66 |
| Removal of fingernails or toenails, 6 or more nails | 72 | $3,258 | $20 |
| Simple separation of fingernail or toenail from nail bed, first nail | 15 | $900 | $47 |
| Short return visit | 19 | $788 | $22 |
| Injection into tendon or ligament | 18 | $651 | $31 |
| Aspiration and/or injection of fluid from medium joint | 16 | $441 | $26 |
| Aspiration and/or injection of fluid from small joint | 11 | $396 | $33 |
2017: 7 services
| Short return visit (20+ min) | 175 | $13,738 | $42 |
| New patient visit (30+ min) | 174 | $11,022 | $63 |
| Return visit (30+ min) | 104 | $6,731 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 32 | $1,089 | $22 |
| Injection into tendon or ligament | 15 | $644 | $36 |
| Simple separation of fingernail or toenail from nail bed, first nail | 11 | $603 | $50 |
| Aspiration and/or injection of fluid from medium joint | 17 | $600 | $26 |
2016: 4 services
| New patient visit (30+ min) | 163 | $10,013 | $61 |
| Short return visit (20+ min) | 112 | $9,213 | $44 |
| Return visit (30+ min) | 57 | $3,995 | $70 |
| Injection into tendon or ligament | 15 | $659 | $39 |
2015: 2 services
| New patient visit (30+ min) | 39 | $2,656 | $68 |
| Short return visit (20+ min) | 19 | $1,187 | $46 |
Medicaid work
$6,842 in 2024
Medicaid paid $6,842 for 225 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 211 | $6,737 |
| Debridement of nail(s) by any method(s); 6 or more | 14 | $105 |
| 2024 | 225 | 2 | 30 | $6,842 |
| 2023 | 473 | 6 | 33 | $7,631 |
| 2022 | 307 | 3 | 30 | $4,989 |
| 2021 | 286 | 3 | 32 | $5,589 |
| 2020 | 262 | 3 | 23 | $4,066 |
| 2019 | 220 | 2 | 23 | $3,370 |
| 2018 | 116 | 2 | 16 | $1,860 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 292 | $4,584 |
| New patient visit (45+ min) | 12 | $838 |
| Debridement of nail(s) by any method(s); 6 or more | 99 | $771 |
| Hospital outpatient clinic visit for assessment and management of a patient | 43 | $655 |
| Return visit (30+ min) | 13 | $460 |
| Service | 14 | $323 |
2022
| Short return visit (20+ min) | 263 | $4,622 |
| Hospital outpatient clinic visit for assessment and management of a patient | 15 | $198 |
| Debridement of nail(s) by any method(s); 6 or more | 29 | $169 |
2021
| Short return visit (20+ min) | 218 | $4,903 |
| Debridement of nail(s) by any method(s); 6 or more | 40 | $399 |
| Hospital outpatient clinic visit for assessment and management of a patient | 28 | $287 |
2020
| Short return visit (20+ min) | 208 | $3,346 |
| Debridement of nail(s) by any method(s); 6 or more | 26 | $418 |
| Hospital outpatient clinic visit for assessment and management of a patient | 28 | $302 |
2019
| Short return visit (20+ min) | 178 | $2,930 |
| Hospital outpatient clinic visit for assessment and management of a patient | 42 | $440 |
2018
| Short return visit (20+ min) | 103 | $1,729 |
| Hospital outpatient clinic visit for assessment and management of a patient | 13 | $131 |
Drugs they prescribed that Part D paid
$7,235
Pharmacies billed $7,235 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
109 generic and 22 brand-name prescriptions · $7,235 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Econazole Nitrate | 32 | $1,012 | $32 |
| Ciclopirox | 15 | $502 | $33 |
| Ssd | 15 | $131 | $9 |
| Lidocaine-Prilocaine | 11 | $125 | $11 |
Year by year
| 2024 | 131 | 65 | None | 17% | $7,235 |
| 2023 | 142 | 69 | None | 23% | $16,732 |
| 2022 | 199 | 90 | None | 24% | $17,455 |
| 2021 | 241 | 102 | None | 17% | $17,933 |
| 2020 | 332 | 128 | None | 16% | $30,780 |
| 2019 | 263 | 116 | None | 14% | $21,020 |
| 2018 | 314 | 124 | None | None | $31,517 |
| 2017 | 235 | 105 | None | None | $22,121 |
| 2016 | 94 | 52 | None | 24% | $12,558 |
| 2015 | 13 | None | None | 0% | $118 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Ciclopirox | 31 | $1,154 | $37 |
| Econazole Nitrate | 26 | $673 | $26 |
| Ssd | 11 | $131 | $12 |
| Silver Sulfadiazine | 12 | $108 | $9 |
2022: 6 drugs
| Ciclopirox | 51 | $1,685 | $33 |
| Ammonium Lactate | 27 | $823 | $30 |
| Econazole Nitrate | 24 | $807 | $34 |
| Gabapentin | 13 | $361 | $28 |
| Silver Sulfadiazine | 25 | $224 | $9 |
| Ssd | 11 | $113 | $10 |
2021: 8 drugs
| Jublia | 12 | $12,481 | $1,040 |
| Ciclopirox | 62 | $1,547 | $25 |
| Diclofenac | 25 | $1,060 | $42 |
| Nitro-Bid | 13 | $631 | $49 |
| Gabapentin | 33 | $433 | $13 |
| Ammonium Lactate | 12 | $397 | $33 |
| Econazole Nitrate | 16 | $206 | $13 |
| Ssd | 13 | $107 | $8 |
2020: 8 drugs
| Jublia | 22 | $22,741 | $1,034 |
| Diclofenac | 79 | $3,478 | $44 |
| Ciclopirox | 47 | $1,278 | $27 |
| Nitro-Bid | 18 | $838 | $47 |
| Gabapentin | 54 | $708 | $13 |
| Econazole Nitrate | 18 | $634 | $35 |
| Ketoconazole | 12 | $299 | $25 |
| Silver Sulfadiazine | 20 | $151 | $8 |
2019: 5 drugs
| Jublia | 13 | $12,703 | $977 |
| Diclofenac | 37 | $2,789 | $75 |
| Ciclopirox | 53 | $1,436 | $27 |
| Econazole Nitrate | 34 | $1,328 | $39 |
| Gabapentin | 41 | $471 | $11 |
2018: 9 drugs
| Jublia | 15 | $17,103 | $1,140 |
| Voltaren | 20 | $3,188 | $159 |
| Econazole Nitrate | 19 | $1,768 | $93 |
| Ciclopirox | 70 | $1,751 | $25 |
| Diclofenac | 17 | $816 | $48 |
| Clotrimazole | 18 | $786 | $44 |
| Gabapentin | 48 | $786 | $16 |
| Ammonium Lactate | 28 | $769 | $27 |
| Terbinafine | 25 | $88 | $4 |
2017: 8 drugs
| Jublia | 12 | $12,546 | $1,046 |
| Econazole Nitrate | 18 | $2,505 | $139 |
| Diclofenac | 22 | $1,921 | $87 |
| Voltaren | 18 | $1,879 | $104 |
| Ciclopirox | 41 | $1,398 | $34 |
| Ammonium Lactate | 27 | $796 | $29 |
| Gabapentin | 25 | $305 | $12 |
| Terbinafine | 36 | $78 | $2 |
2016: 3 drugs
| Jublia | 14 | $9,309 | $665 |
| Meloxicam | 15 | $49 | $3 |
| Terbinafine | 16 | $47 | $3 |
Money from drug and device companies
$284 in 2025
| 2025 | 2 | 4 | None | $284 |
| 2023 | 3 | 3 | None | $278 |
| 2022 | 1 | 1 | None | $98 |
| 2019 | 5 | 5 | None | $445 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Treace Medical Concepts | Tmc Nanoplasty System | $223 | 2 payments
|
| Stryker | Gravity | $62 | 2 payments
|
See all 4 published payments
| Stryker | Meals · 2025-11-18 | Gravity | $38 |
| Stryker | Meals · 2025-11-05 | Phalinx | $24 |
| Treace Medical Concepts | Education · 2025-05-29 | None | $81 |
| Treace Medical Concepts | Meals · 2025-05-29 | Tmc Nanoplasty System | $142 |
See earlier years (2023, 2022, 2019)
2023: $278
| Acera Surgical | Restrata Wound Matrix | $127 | 1 payment
|
| Stryker | Infinity | $124 | 1 payment
|
| Averitas Pharma | Qutenza | $28 | 1 payment
|
2022: $98
| DePuy Synthes Sales | Elite | $98 | 1 payment
|
2019: $445
| Wright Medical Technology | Ortholoc | $123 | 1 payment
|
| DePuy Synthes Sales | Elite | $114 | 1 payment
|
| Evolution Surgical | None | $106 | 1 payment
|
| Zimmer Biomet Holdings | Biomet Orthopak | $63 | 1 payment
|
| Bioventus | Exogen | $39 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1013971621
- Licence
- CA 5119, FL PO 2990California G5119: Deceased
- Trained
- Temple University School of Medicine, 1995
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X); Federal specialty code 213ES0103X (213ES0103X); Federal specialty code 213ES0131X (213ES0131X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94305
- NPI first listed
- 2006-04-12
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.